Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.

Completed

Conditions studied: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder

In brief

This is a screening study aimed at estimating the frequency of antipsychotic non-compliance in patients with a history of schizophrenia or other psychotic disorder admitted to an inpatient psychiatric unit. Levels of the antipsychotics risperidone, olanzapine, quetiapine, aripiprazole, and paliperidone will be drawn in patients presenting the emergency room who are acutely psychotic, require admission to an inpatient hospital, have a history of psychosis, and have previously been prescribed one of the study drugs. Levels will then be analyzed to determine the frequency and severity of non-compliance in this population.

Key facts

Study ID

NCT01786369

Run by

Northwell Health

People needed

106

Starts

2013-02-01

Expected to finish

2015-04-01

Last updated by the study team

2015-04-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Documented diagnosis of schizophrenia, schizoaffective disorder, or bipolar 1 disorder
• Admitted to an inpatient psychiatric unit at Zucker Hillside Hospital for a psychotic decompensation.
• Outpatient for at least one month prior to admission
• On a regimen including risperidone, olanzapine, quetiapine, paliperidone or aripiprazole

You may not qualify if…

• Anti-psychotic polypharmacy
• Diagnosis of Mental Retardation or Pervasive Developmental Disorder
• Administrations of any of study medications in emergency room prior to blood draw.

Where it is running

• Zucker Hillside Hospital — Glen Oaks, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.